RecruitingNCT05450016

Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD)

Sponsor

Tata Memorial Centre

Enrollment

720 participants

Start Date

Oct 4, 2021

Study Type

OBSERVATIONAL

Conditions

Breast Cancer

Summary

Surgery and radiotherapy in breast cancer patients can cause treatment changes and may affect the final breast appearance. In this study, we are trying to evaluate the post treatment breast photographs of the patients and subject these to Artificial Intelligence based program so as to classify into appropriate categories based upon changes from baseline. This automated solution will help in decreasing the time required to achieve this task by physicians in the clinic.

Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study uses a deep learning (AI) program to assess the cosmetic outcome of breast cancer surgery by analyzing photos of patients' breasts before and after treatment. The goal is to develop an objective, computer-based measure of how well the breast looks after cancer surgery, replacing purely subjective assessments. **You may be eligible if...** - You have had breast cancer surgery (lumpectomy or mastectomy) - You are willing to allow photos of your breast area to be taken and analyzed by AI software - You are an adult woman **You may NOT be eligible if...** - You are not comfortable with photographic documentation - You have conditions that would make photo assessment unreliable Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Tata Memorial Centre

Mumbai, Maharashtra, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05450016

Related Trials

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

NCT06790693226 locations

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

NCT058799261238 locations

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

NCT072146624 locations

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

NCT07062965384 locations

Genomic Services Research Program

NCT025959571 location